New business CSM and net profits grew year-over-year, driven by health product expansion and improved investment yields. RBC ratio strengthened, and the company remains focused on high-margin products, stable CSM growth, and shareholder returns.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.